Cumberland Pharmaceuticals Newsroom

US Manufacturing Index Rises To 43, Highest Since 2020

Business TodayNov 16 15:13

Cumberland Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

SECNov 9 06:10 · Announcements

Cumberland Pharmaceuticals Reports Q3 2024 Earnings and Developments

TipRanksNov 8 14:07

Cumberland Q3 Adj $(0.02) Down From $0.02 YoY, Sales $9.09M Down From $10.09M YoY

BenzingaNov 8 06:59

Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Reports Q3 Revenue $9.1M

MT NewswiresNov 8 05:29

Express News | Cumberland Pharmaceuticals Q3 Revenue USD 9.1 Million

BreakingsNov 8 05:05

Express News | Cumberland Pharmaceuticals Q3 Operating Expenses USD 10.8 Million

BreakingsNov 8 05:05

Cumberland Pharma 3Q Loss/Shr 11c >CPIX

Dow JonesNov 8 05:05

Express News | Cumberland Pharmaceuticals Receives FDA Orphan Drug and Rare Pediatric Disease Designations for New Treatment of Duchenne Muscular Dystrophy

BreakingsNov 7 06:21

CUMBERLAND PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG AND RARE PEDIATRIC DISEASE DESIGNATIONS FOR NEW TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

PR NewswireNov 7 06:21

Cumberland Pharmaceuticals Announces The Publication Of New Real-World Outcomes Research Demonstrating The Safety And Healthcare Resource Advantages Of Its Caldolor (Ibuprofen) Injection Over Ketorolac In Both Adult And Pediatric Populations

BenzingaNov 6 05:20

New Study Compares Caldolor (Ibuprofen Injection) to Ketorolac

PR NewswireNov 6 05:05

Express News | Corrected-Cumberland Pharmaceuticals Inc: Evaluating Options for Caldolor Payment (Removes Extraneous Word 'cms')

BreakingsNov 5 06:47

Express News | Cumberland Pharmaceuticals Inc: CMS Excludes Caldolor From Nopain Act Separate Payment List

BreakingsNov 5 06:17

Cumberland Pharmaceuticals (CPIX.US) will release its financial report after the market closes on November 7th.

Cumberland Pharmaceuticals (CPIX.US) will release its earnings report after the market closes on November 7th. How was its previous performance? For 2024 Q2, revenue was $9.848849 million, net income was -$-1.102637 million, and eps was -$0.08. For 2023 Q3, revenue was $10.085926 million, net income was -$-1.063219 million, and eps was -$0.07. The above data is presented in accordance with US GAAP. Futubull reminder: 1. Hong Kong stocks, US

Futu NewsNov 2 09:00

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2024 FINANCIAL RESULTS

PR NewswireNov 1 04:05

Earnings Call Summary | Cumberland Pharmaceuticals(CPIX.US) Q2 2024 Earnings Conference

Futu NewsAug 12 01:30 · Conference Call

Cumberland Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

SECAug 10 05:08 · Announcements

Cumberland Q2 Adj $0.01 Down From $0.16 YoY, Sales $9.85M Down From $10.89M YoY

BenzingaAug 7 05:41

Express News | Cumberland Pharmaceuticals Inc - on Track to Post Significant Revenue Growth and Positive Cashflow From Operations During 2024

BreakingsAug 7 04:51